The Aperlena Verdict
Open raceNo supplier dominates: 7 different companies have won the last 11 comparable contracts from this buyer over 5 years. This is a genuinely open race.
Based on 11 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThe Regional Ministry of Health of Castilla-La Mancha is procuring reagents for the expanded neonatal screening programme of the Institute of Health Sciences (ICS) laboratory, belonging to the Directorate General of Public Health, for the years 2027 to 2030. The supply covers expanded neonatal screening by tandem mass spectrometry, including the loan of a QSight 225 MD LC/MS/MS system with HPLC pump, autosampler, Simplicity software and a nitrogen generator; haemoglobin screening by capillary electrophoresis with loan of a Capillarys 3 DBS system and an external comparison assay; reagents for congenital hypothyroidism, congenital adrenal hyperplasia, cystic fibrosis and biotinidase deficiency on the GSP system; and screening for spinal muscular atrophy and severe combined immunodeficiency by dry chemistry PCR on the Eonis Q96 system. All must integrate with the Specimen Gate software.
Description
Bid or no-bid?
Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.
Can I bid?
- Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
- The notice is written in Spanish.
- Certificates from another EU country? Check the equivalents on eCertis
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 17 hours ago
Expected award price
- likely award for this notice, from its published estimate of €2,356,500
- €1.1M to €2.4M
Comparable awards in this country and sector came in at a median of 89% of their published estimate, half of them between 45% and 100%, based on 1,657 awards of the last 3 years.
Each award is compared with the estimate of the same lots, framework agreements excluded. A published estimate may include options and renewals, so an award under it is not always a discount.
What this buyer has paid before
Based on 10 comparable contracts this buyer awarded in this sector over the last 4 years.
- This notice
- €2.4M
- Median award
- €656,960
- Middle half of past awards
- €72,613 to €900,450
The estimate is larger than three in four past awards.
Most recent awards
- Adquisición de vacuna inactivada de cultivo celular frente a gripe destinada a grupos de riesgo para la temporada otoño-invierno 2026. €462,000
- Contratación del suministro de NIRSEVIMAB (anticuerpo monoclonal frente a enfermedad producida por virus respiratorio sincitial) destinado a la inmunización de neonatos y lactantes en Castilla-La Mancha para la temporada 2026-2027, basada en el Lote 24 del Acuerdo Marco estatal 202507ACM001, para la selección de suministradores de vacunas de calendario y otras y otros productos inmunizantes. €3,135,000
- Adquisición de vacuna de virus vivos atenuados y administración intranasal frente a la gripe destinada a la temporada otoño-invierno 2026-2027 €851,920
- Adquisición de medios de cultivo, cepas, sueros y kits de uso en microbiología para que la Red de Laboratorios de Salud Pública de Castilla-La Mancha pueda desarrollar correctamente su actividad y funciones durante el año 2026. €56,817
- Adquisición de nirsevimab (anticuerpo monoclonal frente a enfermedad producida por virus respiratorio sincitial) destinado a la inmunización de neonatos y lactantes en castilla-la mancha para la temporada 2026-2027 €3,135,000
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
The buyer
Full buyer profileSecretaría General de la Consejería de Sanidad de la Junta de Comunidades de Castilla-La Mancha
- notices in the register
- 30
- awards
- 23
- awarded in total
- €12.3M
Who wins its contracts
Moderately concentrated- different companies won its awards
- 16
- of the awards went to the three most frequent winners
- 36%
- of its calls state an estimated value
- 100%
Based on 22 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Sanofi Aventis, S.A. | 4 | €8.1M | Aug 2026 |
| SEQIRUS SPAIN SL | 2 | €462,000 | Aug 2026 |
| ASTRAZENECA FARMACEUTICA SPAIN, S.A. | 1 | €851,920 | Jul 2026 |
| MERCK SHARP & DOHME DE ESPAÑA, S.A. | 1 | €120,000 | Dec 2017 |
| THERMO FISHER DIAGNOSTICS, S.L.U. | 1 | €56,817 | Jun 2026 |
Based on 11 awards with a linked company profile over the last 5 years.
Market context
Larger than 86% of the open notices in Medical equipment & pharmaceuticals across Europe.
- open now in Medical equipment & pharmaceuticals
- 11,274
- median open notice
- €140,000
Who wins in this market
Many suppliersSpain · Medical equipment & pharmaceuticals
- different companies won awards here
- 4,404
- of the awards went to the three most frequent winners
- 4%
- winners of the last 12 months were new here
- 3,848 of 4,119
- buyers awarded contracts here
- 1,005
Based on 15,445 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners. New: no award from the same buyer or market in the two years before.
Competition
- tenders per lot on average (open and restricted procedures)
- 3.8
- of those lots received a single tender
- 41%
- of the awards went to companies based in another country
- 1%
- of the tenders came from another country
- 1%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
4
days left
€1,684,076
est. value
17
days left
€2,542,198
est. value
Awarded before
Never miss a tender like this
2,791 new notices in Medical equipment & pharmaceuticals in Spain in the last 7 days. Get an email when new ones appear. Free.
Set up my alert